DMACDiaMedica Therapeutics Inc.
$8.71+30% 1Y
$8.71
$5.3352 weeks$9.39
Is the price fair?
What DMAC's price assumes
- Price / book
- 1.61
Price / book · as of 2021-Q4
Details›
- Price / bookas of 2021-Q4
- 1.61
- Market capitalisation53.9 million shares, counted Aug 3, 2026
- $470M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Biotechnology
Ranks #121 of 194 by RyuScore